University of Virginia opens center for ablation research

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 31 No 12
Volume 31
Issue 12

The University of Virginia has opened a state-of-the-art MR-guided focused ultrasound ablation research institute.

The University of Virginia has opened a state-of-the-art MR-guided focused ultrasound ablation research institute. It is designed to become a leading center for translational research and patient care in this new and rapidly evolving field, said provost Dr. Tim Garson on dedication day, Sept 14.

The UVA center will offer uterine fibroid therapy, the first application of the focused ultrasound technology to receive FDA approval. It will also host clinical trials on uterine fibroids and fertility; Parkinson’s disease and epilepsy; liver, brain, breast, and prostate tumors; and pain control from bone tumors. The state of Virginia and the Focused Ultrasound Surgery Foundation covered $7.1 million of the $8 million cost of establishing the institute. Other contributors included GE Healthcare and InSightec, developer of the first FDA-approved MR-guided focused ultrasound ablation system.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.